BIOTRONIK’s Orsiro Mission drug-eluting stent approved by FDA PRODUCT
BIOTRONIK has received U.S. Food and Drug Administration (FDA) approval of its Orsiro Mission bioabsorbable polymer coronary drug-eluting stent system (BP-DES). The company also announced the first US implant and full commercial availability in the U.S.